Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 28
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Acta Anaesthesiol Scand ; 56(1): 17-22, 2012 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-22091897

RESUMO

Myasthenia gravis (MG) is a disease affecting the nicotinic acetylcholine receptor of the post-synaptic membrane of the neuromuscular junction, causing muscle fatigue and weakness. The myasthenic patient can be a challenge to anesthesiologists, and the post-surgical risk of respiratory failure has always been a matter of concern. The incidence and prevalence of MG have been increasing for decades and the disease is underdiagnosed. This makes it important for the anesthesiologist to be aware of possible signs of the disease and to be properly updated on the optimal perioperative anesthesiological management of the myasthenic patient. The review is based on electronic searches on PubMed and a review of the references of the articles. The following keywords were used: myasthenia gravis AND neuromuscular blocking agents, myasthenia gravis AND sevoflurane, myasthenia gravis AND epidural, myasthenia gravis AND neuromuscular blockade reversal and myasthenia gravis AND pyridostigmine. The articles included were from reviews and clinical trials written in English. MG patients can easily be anesthetized without need for post-surgery mechanical ventilation whether it is general anesthesia or peripheral nerve block. Volatile anesthesia or the use of an epidural for the patient makes it possible to avoid the use of neuromuscular blocking agents, and when used, it should be in smaller doses and the patient should be carefully monitored. This review shows that with thorough pre-operative evaluation, continuing the daily pyridostigmine and careful monitoring the MG patient can be managed safely.


Assuntos
Anestesia , Miastenia Gravis/complicações , Anestesia Epidural , Anestésicos Inalatórios , Inibidores da Colinesterase , Humanos , Miastenia Gravis/terapia , Bloqueadores Neuromusculares/efeitos adversos , Bloqueadores Neuromusculares/antagonistas & inibidores , Fármacos Neuromusculares não Despolarizantes , Dor Pós-Operatória/tratamento farmacológico , Assistência Perioperatória , Cuidados Pós-Operatórios , Cuidados Pré-Operatórios , Brometo de Piridostigmina , Respiração Artificial , Sugammadex , gama-Ciclodextrinas/uso terapêutico
2.
Science ; 227(4685): 435-8, 1985 Jan 25.
Artigo em Inglês | MEDLINE | ID: mdl-2578226

RESUMO

Viable Leishmania promastigotes and amastigotes were detected by epifluorescence microscopy with fluorescein diacetate being used to mark living parasites and the nucleic acid-binding compound ethidium bromide to stain dead cells. This procedure is superior to other assays because it is faster and detects viable intracellular as well as extracellular Leishmania. Furthermore, destruction of intracellular pathogens by macrophages is more accurately determined with fluorescein diacetate than with other stains. The procedure may have applications in programs to develop drugs and vaccines against protozoa responsible for human and animal disease.


Assuntos
Etídio , Fluoresceínas , Leishmania/fisiologia , Parasitologia/métodos , Animais , Leishmania/isolamento & purificação , Macrófagos/parasitologia , Camundongos , Microscopia de Fluorescência , Movimento , Coloração e Rotulagem
3.
J Vet Intern Med ; 23(3): 509-13, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-19298610

RESUMO

BACKGROUND: Ionized hypocalcemia (iHCa) is a common electrolyte disturbance in critically ill people, especially those with sepsis. The cause of the iHCa is not entirely understood and is likely multifactorial. Critically ill people with iHCa have longer hospital stays and higher mortality rates compared to people with normocalcemia. There are no published clinical studies evaluating the incidence and impact of iHCa in critically ill dogs. HYPOTHESIS: iHCa occurs in critically ill dogs, is more prevalent in dogs with systemic inflammatory response syndrome (SIRS) or sepsis, and is associated with longer hospital stays and higher mortality. ANIMALS: One hundred and forty-one client-owned dogs admitted to a companion animal intensive care unit (ICU) in a veterinary teaching hospital. METHODS: Prospective observational study of sequentially enrolled dogs. Blood was collected and analyzed within an hour of admission from all dogs presented to the ICU that met study inclusion criteria. RESULTS: The incidence of iHCa (iCa < 1.11 mmol/L) was 16%. The presence of iHCa was associated with longer ICU (P= .038) and hospital (P= .012) stays but not with decreased survival (P= .60). Dogs with sepsis as defined by >or=3 SIRS criteria and a positive culture were more likely to have iHCa (P= .050). CONCLUSIONS AND CLINICAL RELEVANCE: In dogs not previously treated with fluids or blood products intravenously, the finding of iHCa upon admission to the ICU predicted a longer duration of ICU and hospital stay. Septic dogs with positive cultures were more likely to have iHCa.


Assuntos
Doenças do Cão/sangue , Hipocalcemia/veterinária , Animais , Cálcio/sangue , Cálcio/química , Estado Terminal , Doenças do Cão/mortalidade , Cães , Hipocalcemia/sangue , Estudos Prospectivos , Fatores de Risco , Sepse/sangue , Sepse/veterinária
4.
J Leukoc Biol ; 47(1): 64-9, 1990 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-2136748

RESUMO

The interaction of human recombinant interferon-gamma (rIFN-gamma) with human polymorphonuclear cells (PMN) was investigated. Bolton-Hunter radioiodinated rIFN-gamma bound to PMN in a specific and saturable manner. Eleven hundred binding sites were observed with a Ka of 0.56 x 10(10) M-1. Binding to PMN was rapid with a K1 of 9 x 10(5) M-1 sec-1 at 4 degrees C. At 37 degrees C binding was complete within 6 min. About 50% of bound ligand was internalized within 30 min at 37 degrees C. The receptor demonstrated moderate lability at 37 degrees C in culture. After 1 h at 37 degrees C, PMN lost 80% of their 125I-rIFN-gamma binding sites. This loss was reversed in part by the presence of interleukin-1 in the culture, but not tumor necrosis factor. These studies provide a framework for further investigation into the signalling process of rIFN-gamma on PMN.


Assuntos
Interferon gama/metabolismo , Neutrófilos/metabolismo , Receptores Imunológicos/metabolismo , Humanos , Peróxido de Hidrogênio/metabolismo , Técnicas In Vitro , Interleucina-1/farmacologia , Radioisótopos do Iodo , Neutrófilos/efeitos dos fármacos , Receptores de Interferon , Proteínas Recombinantes , Fator de Necrose Tumoral alfa/farmacologia
5.
AIDS Res Hum Retroviruses ; 6(8): 967-71, 1990 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-2223243

RESUMO

Although macrophages are major targets for human immunodeficiency virus (HIV) infection in vivo, study of HIV-macrophage interactions in vitro was hindered because many laboratory strains of HIV would not replicate in macrophages, and because survival of macrophages in culture was poor. Addition of purified macrophage colony-stimulating factor (M-CSF) to cultured macrophages markedly improves their survival, but does not induce proliferation. HIV isolates that replicate in macrophages will also replicate in lymphocytes; however, isolates adapted to lymphoid cells (such as HIV-HTLVIIIB) will not replicate in macrophages. The envelope gene appears to be a major determinant of the cell tropism of viral isolates. T-cell grown virus stocks synthesize abundant gp120, while virus grown in macrophages contains relatively much less gp120. Electron microscopy of virions from macrophages shows them to be depleted of gp120 surface "spikes." Recombination studies show that the portion of the genome coding for the envelope glycoprotein appears to determine cell tropism. Lastly, rsCD4 neutralized macrophage-tropic isolates less efficiently than T-cell tropic isolates. HIV replication in macrophages is partially under the control of cellular factors, although these have been less well characterized than they have in lymphocytes.


Assuntos
Infecções por HIV/imunologia , HIV/patogenicidade , Macrófagos/microbiologia , Suscetibilidade a Doenças , HIV/efeitos dos fármacos , Humanos , Fator Estimulador de Colônias de Macrófagos/farmacologia , Macrófagos/efeitos dos fármacos , Linfócitos T/efeitos dos fármacos , Linfócitos T/microbiologia , Replicação Viral/efeitos dos fármacos , Replicação Viral/imunologia
6.
AIDS Res Hum Retroviruses ; 6(8): 1045-9, 1990 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-2121192

RESUMO

Human recombinant interferon-alpha (IFN alpha) restricted viral replication in human immunodeficiency virus- (HIV) infected T cells and monocytes. With T cells, reverse transcriptase (RT) activity in culture fluids was reduced threefold from that of control infected cells by IFN treatment, but HIV p24 antigen levels were unchanged. In contrast, levels of p24 antigen and RT activity in lysates of IFN-treated infected cells were threefold greater than those of controls. These differences suggest that the mechanism for IFN-induced antiviral effects in HIV-infected T cells resides in the terminal events (assembly and release) of the virus replication cycle. Monocytes treated with IFN at the time of virus challenge showed no p24 antigen or RT activity, no HIV-specific mRNA, and no proviral DNA in cells for up to 3 weeks after infection. IFN treatment of chronically infected monocytes also decreased virus replication, as assessed by p24 antigen, mRNA and RT detection assays. However, levels of proviral DNA in the IFN-treated and control HIV-infected cells were indistinguishable. The presence of large quantities of proviral DNA in cells with little or no evidence for active transcription documents a situation approaching true microbiological latency.


Assuntos
HIV/efeitos dos fármacos , Interferon Tipo I/farmacologia , Monócitos/microbiologia , Linfócitos T/microbiologia , DNA Viral/análise , Relação Dose-Resposta a Droga , Produtos do Gene gag/imunologia , HIV/genética , HIV/imunologia , Antígenos HIV/análise , Proteína do Núcleo p24 do HIV , Infecções por HIV/tratamento farmacológico , Humanos , Interferon Tipo I/administração & dosagem , Monócitos/efeitos dos fármacos , RNA Viral/análise , Proteínas Recombinantes , Linfócitos T/efeitos dos fármacos , Proteínas do Core Viral/imunologia , Replicação Viral/efeitos dos fármacos
7.
Intensive Care Med ; 16(4): 267-8, 1990.
Artigo em Inglês | MEDLINE | ID: mdl-2358561

RESUMO

A fast progressing lethal case of neuroleptic malignant syndrome (NMS) complicated by disseminated intravascular coagulation (DIC) is presented. The fulminant course is infrequent and relates NMS to malignant hyperthermia. Muscular relaxation in combination with fluid load dramatically decreased the temperature, but the catastrophic course of this case was so advanced that the currently recommended treatment of NMS was impossible.


Assuntos
Coagulação Intravascular Disseminada/complicações , Síndrome Maligna Neuroléptica/complicações , Adulto , Coagulação Intravascular Disseminada/sangue , Coagulação Intravascular Disseminada/fisiopatologia , Humanos , Unidades de Terapia Intensiva , Masculino , Síndrome Maligna Neuroléptica/fisiopatologia , Síndrome Maligna Neuroléptica/terapia
8.
J Parasitol ; 63(5): 800-4, 1977 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-915608

RESUMO

The maximal rate of glucose influx in Hymenolepis diminuta decreased when CL- in the incubation medium was replaced with acetate, benzoate, bicarbonate, formate, hippurate, iodide, lactate, mandelate, or nitrate. The effect of Cl- deletion on glucose influx using any of these anions was reversed when worms were incubated in Krebs-Ringer saline for 15 min. Glucose in the incubation medium increased 36Cl- influx in worms, while in Na+-free media the presence of glucose had no effect on 36Cl- influx. Influx of 10 mM 36Cl- in H. diminuta was inhibited by unlabeled Cl- in the incubation medium. Hymenolepis diminuta accumulated glucose aginst an apparent concentration differnce when Cl- in the incubation media was replaced with acetate, bicarbonate, or nitrate. The influx of Cl- appears couples with the influxes of Na+ and glucose, but the data do not show whether the influxex of these molecules are mediated through a common "carrier."


Assuntos
Cestoides/metabolismo , Cloretos/farmacologia , Glucose/metabolismo , Hymenolepis/metabolismo , Animais , Transporte Biológico Ativo/efeitos dos fármacos , Cloretos/metabolismo , Masculino , Ratos , Sódio/metabolismo
9.
J Parasitol ; 66(2): 205-12, 1980 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-6993639

RESUMO

The absorption of 3H-labeled adenine, adenosine, hypoxanthine, and 14C-labeled inosine by normal rat erythrocytes, Plasmodium bergheri-infected erythrocytes and saponin released "free parasites" was measured. The uptake of these labeled substrates by normal rat erythrocytes occurs both by diffusion and mediated transport systems. Similar absorptive mechanisms for these substrates also were observed for both Plasmodium berghei-infected erythrocytes and "free parasites." Data from inhibition studies using purine base and nucleoside analogues indicate the presence of three distinct transport loci in the normal erythrocyte for adenosine-inosine, hypoxanthine, and adenine and two loci in the infected erythrocyte and "free parasite" for adenosine-inosine-hypoxanthine and adenine. The initial metabolism of 3H-adenosine by the "free parasite" also was examined. A double isotope technique was used to follow the separate metabolic fates of the purine base and ribose moieties of adenosine. The data suggest a possible conversion of adenosine to the purine base and ribose moiety and subsequent uptake of the purine base by the parasite. In addition, a powerful adenosine deaminase inhibitor (2-deoxcoformycin) significantly reduced the uptake of 3H-adenosine by the "free parasites." Chromatographs of aliquots from postincubation media show the tritium label to be associated predominately with adenosine in the presence of 2-deoxycoformycin and with isoine and hypoxanthine in the absence of the inhibitor.


Assuntos
Eritrócitos/metabolismo , Plasmodium berghei/metabolismo , Nucleosídeos de Purina/metabolismo , Purinas/metabolismo , Adenina/metabolismo , Adenosina/metabolismo , Animais , Transporte Biológico Ativo , Difusão , Eritrócitos/parasitologia , Hipoxantinas/metabolismo , Inosina/metabolismo , Cinética , Masculino , Ratos
10.
Res Vet Sci ; 65(3): 245-51, 1998.
Artigo em Inglês | MEDLINE | ID: mdl-9915151

RESUMO

The effects of transdermal fentanyl and i.m. oxymorphone on behavioural and physiological responses, after ovariohysterectomy in dogs, were investigated. The study involved three groups of 10 dogs: fentanyl/surgery (FS), oxymorphone/surgery (OS), fentanyl/control (FC). A transdermal fentanyl delivery system (50 microg hour(-1)) (FS and FC) was applied 20 hours before surgery, or i.m. oxymorphone (OS) was administered. After ovariohysterectomy (FS and OS) or anaesthesia alone (FC), dogs were continuously videotaped for 24 hours and a standardised hourly interaction with a handler performed. The videotapes were analysed, and interactive and non-interactive behaviours evaluated. In addition, pain and sedation scores, pulse and respiratory rates, rectal temperature, arterial blood pressure, plasma cortisol and plasma fentanyl concentrations were measured. This study showed that transdermal fentanyl and i.m. oxymorphone (0.05 mg kg(-1)) produced comparable analgesic effects over a 24 hour recording period. I.m. oxymorphone produced significantly more sedation and lower rectal temperatures than transdermal fentanyl. There were no significant differences between groups in respiratory and heart rates, and arterial blood pressures.


Assuntos
Analgésicos Opioides/administração & dosagem , Analgésicos Opioides/farmacologia , Comportamento Animal/efeitos dos fármacos , Fentanila/administração & dosagem , Fentanila/farmacologia , Histerectomia/veterinária , Ovariectomia/veterinária , Oximorfona/administração & dosagem , Oximorfona/farmacologia , Administração Cutânea , Animais , Cães , Feminino , Injeções Intramusculares , Período Pós-Operatório
11.
J Obstet Gynecol Neonatal Nurs ; 18(5): 392-4, 1989.
Artigo em Inglês | MEDLINE | ID: mdl-2795276

RESUMO

Prader-Willi Syndrome (PWS) is a relatively common complex genetic disorder that is diagnostically and therapeutically challenging to health-care professionals. Nursing observations of significant neonatal feeding problems may assist in identification of the infant with PWS. Once nurses become familiar with the characteristics of this multi-system condition, they can provide specific assistance to PWS infants and their families.


Assuntos
Síndrome de Prader-Willi/enfermagem , Comportamento Alimentar , Humanos , Recém-Nascido , Avaliação em Enfermagem , Pais/educação , Pais/psicologia , Síndrome de Prader-Willi/diagnóstico , Síndrome de Prader-Willi/fisiopatologia
12.
J Am Vet Med Assoc ; 208(3): 366-70, 1996 Feb 01.
Artigo em Inglês | MEDLINE | ID: mdl-8575966

RESUMO

OBJECTIVE: To compare the efficacy of 7% NaCl solution (hypertonic saline) in 6% dextran 70 solution (HSD) with that of lactated Ringer's solution (LRS) for treatment of dogs in traumatic shock. DESIGN: Prospective, randomized, clinical study. ANIMALS: 16 traumatized adult dogs with clinical signs of shock. PROCEDURE: Physical, hemodynamic, blood gas, and clinical chemistry measurements were performed prior to treatment. Initial treatment consisted of HSD (n = 8) or LRS (n = 8) administered as a bolus (5 ml/kg of body weight, IV) over a 3-minute period, followed by administration of additional LRS and other treatments to restore hemodynamic and physical criteria to within reference limits. Measurements were repeated for 3 hours after initial treatment. The volumes of LRS and HSD administered were recorded hourly. Degree of injury was scored by using a trauma severity index. RESULTS: Dogs responded similarly to the treatments, and all but 3 dogs survived to be discharged. The amount of fluid administered to dogs in the HSD group over the final 2 hours of the study was significantly less than that administered to the dogs in the LRS group. Serum sodium concentration and osmolality of the dogs in the HSD group were not significantly greater than those values in the LRS group. Bradyarrhythmias were observed in 2 dogs in the HSD group. CLINICAL IMPLICATIONS: Hypertonic sodium chloride/dextran solution is safe and effective for resuscitating dogs in traumatic shock. Seven percent NaCl in 6% dextran 70 may reduce the need for isotonic fluids in the hours after initial resuscitation.


Assuntos
Dextranos/uso terapêutico , Doenças do Cão/terapia , Cães/lesões , Hidratação/veterinária , Substitutos do Plasma/uso terapêutico , Solução Salina Hipertônica/uso terapêutico , Choque Traumático/veterinária , Acidentes de Trânsito , Animais , Soluções Isotônicas/uso terapêutico , Estudos Prospectivos , Lactato de Ringer , Choque Traumático/terapia , Índices de Gravidade do Trauma , Resultado do Tratamento
13.
Vet Clin North Am Small Anim Pract ; 26(5): 1185-201, 1996 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-8863396

RESUMO

Stewart's strong ion difference, first introduced more than 10 years ago, offers an innovative approach for the analysis of non-respiratory acid-base disorders. This article addresses the concept of strong ion difference and discusses its clinical applications. A brief review of base excess and anion gap is also included. Clinical cases are provided to demonstrate a step-by-step method using strong ion difference to evaluate nonrespiratory acid-base imbalances.


Assuntos
Desequilíbrio Ácido-Base/veterinária , Doenças do Gato/metabolismo , Doenças do Cão/metabolismo , Equilíbrio Ácido-Base , Desequilíbrio Ácido-Base/metabolismo , Desequilíbrio Ácido-Base/fisiopatologia , Animais , Gasometria , Doenças do Gato/fisiopatologia , Gatos , Doenças do Cão/fisiopatologia , Cães
14.
Ugeskr Laeger ; 153(8): 573-5, 1991 Feb 18.
Artigo em Dinamarquês | MEDLINE | ID: mdl-2008743

RESUMO

During the period 1 January 1989 to 31 December 1989, a total of 1,004 patients were submitted to outpatient single-day surgery in Aalborg Hospital. As fas as possible, the patients were anaesthetized with propofol (Diprivan)/alfentanil (Rapifen) and oxygen and atmospheric air. This form of anaesthesia was found to be rapid and suitable for single-day surgery. 8.1% of the patients required admission for further observation, 2.3% of these on account of anaesthesiological complications. It is concluded that, by means of meticulous planning, it is possible to carry out ambulant anaesthesia and surgery and, employing limited staff resources, it has proved possible to reduce the waiting time for outpatient intervention to 10-12 weeks.


Assuntos
Procedimentos Cirúrgicos Ambulatórios , Anestesia por Inalação/métodos , Ortopedia , Adolescente , Adulto , Idoso , Alfentanil/administração & dosagem , Procedimentos Cirúrgicos Ambulatórios/estatística & dados numéricos , Período de Recuperação da Anestesia , Anestesia por Inalação/efeitos adversos , Criança , Dinamarca , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Propofol/administração & dosagem
20.
Exp Parasitol ; 58(1): 101-9, 1984 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-6745384

RESUMO

Leishmania mexicana mexicana promastigotes, axenic amastigotes, and amastigotes derived from Vero cells were examined for de novo purine synthesis and mechanisms of purine salvage. Both promastigotes and axenic amastigotes were incapable of de novo purine synthesis, as shown by the lack of [14C]formate and [14C]glycine incorporation into purine nucleotide pools. However, the ready incorporation of [14C]hypoxanthine, [14C]adenine, and [14C]guanine suggested that purine salvage pathways were operating. In addition, a significant percentage (greater than or equal to 60%) of the total label from these purine precursors was associated with adenylate nucleotides. Nucleotide pool levels of axenic amastigotes were consistently greater but the specific activities were less than those of promastigotes, suggesting a slower rate of purine metabolism in the axenic amastigote form. Similar results were obtained from amastigotes isolated from infected Vero cells.


Assuntos
Adenina/metabolismo , Guanina/metabolismo , Hipoxantinas/metabolismo , Leishmania/metabolismo , Nucleotídeos de Adenina/biossíntese , Animais , Linhagem Celular , Chlorocebus aethiops , Nucleotídeos de Guanina/biossíntese , Hipoxantina , Leishmania/crescimento & desenvolvimento , Nucleotídeos de Purina/biossíntese
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA